T. Rowe Price's January AUM Balance Increases 2.7% Sequentially — Positive

TROW   Zacks Investment Research — February 13, 2025

TROW's January AUM balance was $1.65 trillion. It experiences net outflows of $2.1 billion for the month.

image for news T. Rowe Price's January AUM Balance Increases 2.7% Sequentially

Toll Brothers Stock Before Q1 Earnings Release: To Buy or Not to Buy? — Negative

TOL   Zacks Investment Research — February 13, 2025

TOL's fiscal first-quarter results are likely to reflect affordability issues and margin pressure amid strategic initiatives.

image for news Toll Brothers Stock Before Q1 Earnings Release: To Buy or Not to Buy?

Trade Tracker: Josh Brown sells Trade Desk — Negative

TTD   CNBC Television — February 13, 2025

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's selling Trade Desk. The stock is getting crushed today after missing earnings.

image for news Trade Tracker: Josh Brown sells Trade Desk

Reddit stock falls despite strong Q4 earnings report — Neutral

RDDT   Yahoo Finance — February 13, 2025

Reddit (RDDT) shares slip lower Thursday morning after the social media platform beat fourth quarter revenue and earnings estimates, while daily active users fell below expectations (101.7 million vs. analyst consensus forecasts for 103.8 million).

image for news Reddit stock falls despite strong Q4 earnings report

Trade Tracker: Kevin Simpson buys Palo Alto — Positive

PANW   CNBC Television — February 13, 2025

Kevin Simpson, Capital Wealth Planning founder and CIO, joins CNBC's 'Halftime Report' to explain why he's getting into Palo Alto. The Investment Committee also discuss cyber stocks.

image for news Trade Tracker: Kevin Simpson buys Palo Alto

Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript — Neutral

AGIO   Seeking Alpha — February 13, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO ) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Brian Goff - CEO Sarah Gheuens - CMO & Head OF R&D Tsveta Milanova - CCO Cecilia Jones - CFO Chris Taylor - VP, IR & Corporate Communications Conference Call Participants Eric Schmidt - Cantor Fitzgerald Divya Rao - TD Cowen Gregory Renza - RBC Capital Markets Greg Harrison - Scotiabank Chris Raymond - Piper Sandler Alec Stranahan - Bank of America Lydia Erdman - Goldman Sachs Tessa Romero - J.P. Morgan Operator Good morning, and welcome to Agios' fourth quarter 2024 …

image for news Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript

Blackstone plans to take out a loan of about $800 million to finance the purchase of a stake in a 50-story office building in New York City, according to two sources familiar with the matter.

image for news Exclusive: Blackstone seeks $800 million loan to finance New York office purchase, sources say

Deere Q1 Earnings Top Estimates, Sales Fall Y/Y on Low Volumes — Neutral

DE   Zacks Investment Research — February 13, 2025

DE's Q1 results reflect the impacts of lower shipment volumes and sales mix.

image for news Deere Q1 Earnings Top Estimates, Sales Fall Y/Y on Low Volumes

CoStar Group Set to Report Q4 Earnings: What's in Store for the Stock? — Positive

CSGP   Zacks Investment Research — February 13, 2025

CSGP's fourth-quarter 2024 top line is likely to have reflected a robust portfolio of marketplaces, which includes Apartments.com, LoopNet and Homes.com.

image for news CoStar Group Set to Report Q4 Earnings: What's in Store for the Stock?

Why Datadog Stock Is Plummeting Today — Negative

DDOG   The Motley Fool — February 13, 2025

Shares of Datadog Inc (DDOG -9.49%) are trading lower on Thursday. The company's stock lost 8.4% as of noon ET but lost as much as 11.6% earlier in the day.

image for news Why Datadog Stock Is Plummeting Today

Hanesbrands Earnings Beat Estimates in Q4, Sales Increase Y/Y — Positive

HBI   Zacks Investment Research — February 13, 2025

HBI Q4 results reflect higher net sales and earnings. The gross margin expands 410 bps y/y on accelerated cost-saving initiatives and reduced input costs.

image for news Hanesbrands Earnings Beat Estimates in Q4, Sales Increase Y/Y

Snowflake Rises 22% Year to Date: Buy, Sell or Hold the Stock? — Positive

SNOW   Zacks Investment Research — February 13, 2025

SNOW is benefiting from strong AI partnerships, an expanding client base and strategic acquisitions amid intense competition and a stretched valuation.

image for news Snowflake Rises 22% Year to Date: Buy, Sell or Hold the Stock?

AEIS Q4 Earnings & Revenues Beat, Stock Rises on Stable Outlook — Neutral

AEIS   Zacks Investment Research — February 13, 2025

Advanced Energy's fourth-quarter results highlight strong Data Center and Semiconductor demand despite headwinds in the Industrial, Medical and Telecom sectors.

image for news AEIS Q4 Earnings & Revenues Beat, Stock Rises on Stable Outlook

Reddit Q4 Earnings & Revenues Top Estimates: Buy, Sell or Hold Stock? — Positive

RDDT   Zacks Investment Research — February 13, 2025

RDDT's fourth-quarter 2024 results benefit from strong top and bottom-line growth, rising user numbers, and international expansion.

image for news Reddit Q4 Earnings & Revenues Top Estimates: Buy, Sell or Hold Stock?

Can MKSI's Solid Q4 Earnings and 1Q25 View Push the Stock Higher? — Positive

MKSI   Zacks Investment Research — February 13, 2025

MKS Instruments' fourth-quarter results reflect strength in the Semiconductor and Electronics & Packaging market amid sluggish Specialty Industrial demand.

image for news Can MKSI's Solid Q4 Earnings and 1Q25 View Push the Stock Higher?

Unilever Q4 Margins Up, Revenue Misses — Positive

UL   The Motley Fool — February 13, 2025

Consumer goods manufacturing giant Unilever (UL -5.46%) reported mixed fourth-quarter and full-year 2024 earnings on Thursday, Feb. 13. Its underlying earnings per share (EPS) of 2.98 British pounds narrowly exceeded analyst consensus expectations of 2.965 pounds thanks to solid operational efficiency.

image for news Unilever Q4 Margins Up, Revenue Misses

Options Trades: Bullish Strategies in NVDA and BA — Positive

NVDA   Schwab Network — February 13, 2025

Kevin Hincks provides example options trades for Nvidia (NVDA) and Boeing (BA). Nvidia reports earnings on February 26.

image for news Options Trades: Bullish Strategies in NVDA and BA

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX) concerning possible violations of federal securities laws. On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial's independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

image for news Pliant Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - PLRX

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=129355&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Cardlytics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129356&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Edison Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - EIX